Cargando…
Dual orexin receptor antagonists for insomnia in youth with neurodevelopmental disorders: a case series and review
Insomnia is a common, impairing, and difficult-to-treat comorbidity in children with neurodevelopmental disorders (NDDs). Behavioral interventions can be challenging because of developmental and behavioral features that interfere with treatment. Medication management also can be difficult due to a h...
Autores principales: | Besterman, Aaron D., Jeste, Shafali S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10038945/ https://www.ncbi.nlm.nih.gov/pubmed/34611728 http://dx.doi.org/10.1007/s00787-021-01883-7 |
Ejemplares similares
-
The diagnostic journey of genetically defined neurodevelopmental disorders
por: Simon, Juliana, et al.
Publicado: (2022) -
Correction: The diagnostic journey of genetically defined neurodevelopmental disorders
por: Simon, Juliana, et al.
Publicado: (2023) -
Orexin receptor antagonists as therapeutic agents for insomnia
por: Equihua, Ana C., et al.
Publicado: (2013) -
Dual orexin receptor antagonists for the treatment of insomnia: systematic review and network meta-analysis
por: Rocha, Rebeka Bustamante, et al.
Publicado: (2023) -
Suvorexant: The first orexin receptor antagonist to treat insomnia
por: Dubey, Ashok K., et al.
Publicado: (2015)